Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Mayo Clinic
Study ID
NCT06353191
Status
Recruiting
Apply to this trial

Conditions

  • Hematopoietic and Lymphatic System Neoplasm
  • Malignant Solid Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study evaluates why some cancer patients but not others experience changes in heart function following treatment with chemotherapy.

Key Dates

Start date
May 3, 2019
Status verified
Feb 2026
Primary completion
Dec 31, 2031
Completion
Dec 31, 2031

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Observational
    Patients undergo blood sample collection and have their medical records reviewed on study.

Primary Outcome Measure

Collection of biospecimens from patients who developed cardiac toxicity (CRCT) or who are at high risk for developing CRCT [ Time Frame: Baseline ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Mayo Clinic in ArizonaScottsdaleArizona85259
Clinical Trials Referral Office
[email protected]
855-776-0015
Myrah Manuel
[email protected]
480-574-3157
Lida A. Mina, MD (PRINCIPAL_INVESTIGATOR)
Mayo Clinic in FloridaJacksonvilleFlorida32224-9980
Clinical Trials Referral Office
[email protected]
855-776-0015
Pamela Williamson
[email protected]
904-953-4694
Nadine Norton, PhD (PRINCIPAL_INVESTIGATOR)
Moffitt Cancer CenterTampaFlorida33612
Aixa Soyano, MD
[email protected]
813-745-8268
Aixa Soyano, MD (PRINCIPAL_INVESTIGATOR)
Mayo Clinic in RochesterRochesterMinnesota55905-

Find similar trials in Scottsdale, AZ

By research site
Mayo Clinic in Arizona· Scottsdale, AZMayo Clinic in Florida· Jacksonville, FLMoffitt Cancer Center· Tampa, FLMayo Clinic in Rochester· Rochester, MN

Related Studies